References
- Pocock S. J., Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31: 103–115
- Verberk W. J., Kroon A. A., Kessels A. G., Dirksen C., Nelemans P. J., Lenders J. W., et al. Home versus Office blood pressure MEasurements: Reduction of Unnecessary treatment Study: rationale and study design of the HOMERUS trial. Blood Press 2003; 12: 326–333
- 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053
- Devereux R. B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618
- Williams B., Poulter N. R., Brown M. J., Davis M., McInnes G. T., Potter J. F., et al. British Hypertension Society guidelines for hypertension management 2004 (BHS‐IV): Summary. BMJ 2004; 328: 634–640
- Meier P. Stratification in the design of a clinical trial. Control Clin Trials 1981; 1: 355–361
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34: 585–612
- Birkett N. J. Adaptive allocation in randomized controlled trials. Control Clin Trials 1985; 6: 146–155
- Feinstein A. R., Landis J. R. The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. J Chronic Dis 1976; 29: 277–284
- Miettinen O. S. Stratification by a multivariate confounder score. Am J Epidemiol 1976; 104: 609–620
- Grizzle J. E. A note on stratifying versus complete random assignment in clinical trials. Control Clin Trials 1982; 3: 365–368
- Kernan W. N., Viscoli C. M., Makuch R. W., Brass L. M., Horwitz R. I. Stratified randomization for clinical trials. J Clin Epidemiol 1999; 52: 19–26
- Simon R. Restricted randomization designs in clinical trials. Biometrics 1979; 35: 503–512
- Armitage P., Gehan E. A. Statistical methods for the identification and use of prognostic factors. Int J Cancer 1974; 13: 16–36
- Therneau T. M. How many stratification factors are “too many” to use in a randomization plan?. Control Clin Trials 1993; 14: 98–108
- Altman D. G., Bland J. M. Treatment allocation by minimisation. BMJ 2005; 330: 843
- Brown M. J., Palmer C. R., Castaigne A., de Leeuw P. W., Mancia G., Rosenthal T., et al. Morbidity and mortality in patients randomised to double‐blind treatment with a long‐acting calcium‐channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366–372
- Cifkova R., Erdine S., Fagard R., Farsang C., Heagerty A. M., Kiowski W., et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003; 21: 1779–1786